Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-247

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-247-90 (Atorvastatin 20 mg 30 Bottle Label)

This is a description of a package of Atorvastatin Calcium 20mg tablets with 90 film coated tablets that are oval-shaped and white or off-white in colour. The tablets are packaged by Proficient Rx LP in Thousand Oaks, CA and the product ID is QA024790. The tablets are only available by prescription, and the Lot # is 00000. The manufacturer is Intas Phamaceuticals Liited, located in Ahmedabad-382, India. The tablets should be stored at 20°-25°C (66°-77°F) and the medication should be kept out of reach of children. The package also includes an expiry date of 00/00/00.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

This appears to be a summary of a clinical trial comparing the effects of a placebo drug versus Atorvastatin on a primary endpoint over a four-year period. The cumulative hazard ratio is shown in a graph for both groups. It indicates that the use of Atorvastatin was associated with lower risk, with an HR of 0.63 (95% CI 0.48-0.83, p=0.001), compared to the placebo. The primary endpoint and details about the trial are not available from this text.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

The text provides a table with percentages of subjects who experienced an event, followed by the dosages of Atorvastatin 10 mg and 80 mg, and their respective hazard ratio with confidence interval and p value. The table appears to include data related to some kind of clinical trial, and it seems that the trial may have been monitoring the incidence of major cardiovascular endpoints over time. However, without additional context or further information, it is not possible to provide a more specific description of the text.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.